2024-12-13 10:29:17
The moderate increase in inflation in the United States consolidated the expectation of interest rate cuts in December. According to the data released by the US Department of Labor on December 11, local time, the US consumer price index (CPI) increased by 0.3% in November, an increase of 0.1 percentage point over October. Inflation continues to rise moderately, which is in line with the market's previous judgment and also supports the expectation that the Fed will continue to cut interest rates this month. However, considering the slowdown in inflation and the increase in uncertainties affecting the economy, many analysts believe that the Fed may slow down the pace of interest rate cuts in the future. (Economic Information Daily)Guotai Junan: It is suggested that the beauty care sector with product and channel changes and flexibility should be optimized from the bottom up. Guotai Junan said that after the pressure of consumption in 2022 and the destocking of consumers in 2023, the beauty consumption will return to the normal purchase cycle in 2024, and the industry prosperity will improve month-on-month, and the double-digit growth of online beauty will be achieved. However, after the channel dividend subsided, the platform traffic and price competition became fierce, and the brand differentiation further intensified. Relying on the product innovation and channel operation ability brought by organizational efficiency, the performance of domestic products in the head is still bright, and the rise of new domestic products has spread from beauty cosmetics to personal care. Looking forward to 2025, the market risk appetite will be significantly restored. Because of its many changes and the rising trend of domestic products as a whole, the American nursing sector has obvious growth attributes and significantly benefited from its style. Brand differentiation in the fundamental dimension has intensified, and it is suggested that the flexible target with product and channel changes should be optimized from bottom to top.Luxury car dealers "switch to" domestic brands, and the competition between new and old forces spread to the channel side. Recently, Beijing Huayang Aotong Automobile Sales Co., Ltd. (referred to as "Huayang Aotong") announced that "the company will no longer continue the distribution business of Audi brands, but will continue to engage in the maintenance business of Audi models". On December 12, the reporter went to Huayang Aotong in Laiguangying, Beijing. The above announcement was posted at the entrance, and the store has been replaced with the "AITO" logo. There is no Audi car in the store, and it has been replaced by two models for sale in the world. A luxury brand dealer who did not want to be named revealed to reporters that Huayang Aotong had indeed been cancelled by Audi, and Zhengzhou Zhongsheng Huidi Store was also withdrawn from the network with it, all because it switched to Huawei's channel network without permission. "The war between new forces and traditional car companies has burned from the product side to the channel side." According to Zhang Xiuyang, secretary-general of China Passenger Car Industry Alliance, the "price war" that lasted for nearly two years has made it difficult for car dealers who are in retail terminals and have been upside down all the year round, and their loyalty has also declined. At the same time, in the tide of the era of smart cars, the concept of consumption is changing rapidly, and the high-end electric vehicle brands in China are gradually winning the wide favor of the market and consumers. (Securities Daily)
The yen once fell to 152.74 against the US dollar, and the trend fluctuated after the release of the Bank of Japan's short-term survey. After the release of the Bank of Japan's short-term survey, the yen initially rose slightly, but then weakened. The yen once fell 0.1% against the US dollar to 152.74. The 10-year Japanese government bond futures rose 4 points to 142.49.Korean media: South Korean President Yin Xiyue tried to appoint a new defense minister. The East Asia Daily did not explain that the source reported that South Korean President Yin Xiyue tried to appoint a new defense minister, which indicated that Yin Xiyue might resume his job, although he said last week that he would let the ruling party decide how to stabilize future state affairs and his term of office. After making a public speech on Thursday, Yin Xiyue approved the 42 agendas adopted at this week's cabinet meeting. This shows that Yin Xiyue may exercise the presidential power immediately after he hinted in his speech that he had no intention of stepping down.Onlikon: The cooperative product Aidit calcitonin soft capsules is planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13th, and on December 12th, the company received a notice from its partner Beijing Meifurun Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Meifurun") that the Aidit calcitonin soft capsules jointly developed by the company and its wholly-owned subsidiary Wenzhou Haihe Pharmaceutical Co., Ltd. are planned to be selected for the tenth batch of national centralized drug procurement. According to the Pharmaceutical Cooperation Agreement signed by the company and its partner Mei Furun, the company owns 50% of the cooperative products.
Warner Bros. Discovery will be reorganized into two major departments. Warner Bros. Discovery said that it will be reorganized into two operating departments, one focusing on traditional cable TV business and the other focusing on streaming media and studios, which may pave the way for the company's future transactions. Warner Bros. Exploration said that it will merge its current Max and Discovery+ streaming media services and HBO departments with another department including Warner Bros.' film and television production business.Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.Compared with the beginning of the personal pension system, the number of participating insurance companies has increased nearly four times, and insurance companies have become an important supplier of personal pension products. The comprehensive opening of the personal pension system will undoubtedly create a historical opportunity for the insurance industry to participate more deeply in the construction of the third pillar. (SSE)
Strategy guide 12-13
Strategy guide 12-13
Strategy guide